Hyperbaric or isobaric low-dose intrathecalropivacaine with or without fentanyl for spinal anesthesia in Chinese parturients undergoing cesarean delivery

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR-TRC-13003177

Enrollment

Unknown

Registered

2013-04-24

Start date

2013-06-01

Completion date

Unknown

Last updated

2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

spinal anesthesia for cesarean delivery

Interventions

A:1% ropivacaine 1ml+normal saline 1ml

B:1% ropivacaine 1ml+50% glucose injection 0.2 ml + normal saline 1ml

C:1% ropivacaine 1ml+fentanyl 0.4 ml + normal saline 0.6ml

D:1% ropivacaine 1ml+50% glucose injection 0.2 ml+fentanyl 0.4 ml + normal saline 0.4ml

Eligibility

Sex/Gender

Female

Age

20 Years to 45 Years

Inclusion criteria

Inclusion criteria: 1. aged 20-45 years; 2. BMI<=35; 3. ASA I-II; 4. selected cesarean delivery; 5. No contraindication for intrathecal anesthesia.

Exclusion criteria

Exclusion criteria: 1. allergic to local anesthetics and main analgesic; 2. drug abuse; 3. bronchial asthma needed regular therapy; 4. neuropsychiatric disorder and cardiovascular disorders; 5. gestational diabetes; 6. eclampsia; 7. bleeding or blood coagulation disorders; 8. fetal distress; 9. known fetal anomaly.

Design outcomes

Primary

Measure	Time frame
sensory block level;motor block;analgesia during operation;time to first pain after operation;postoperation analgesia VAS;	—

Secondary

Measure	Time frame
hypotension;bradycardia;	—

Countries

China

Contacts

Public ContactGONG Hui

gonghui618@yeah.net+86 029 87234786

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026